Summary
Eugene Lepekhin is an independent drug development expert with 15 years of hands-on experience translating academic discoveries into preclinical and early clinical programs across peptides, small molecules, targeted liposomes and long-release formulations. He has led non-clinical development, IND-enabling studies and regulatory submissions in North America and Europe, and built oncology and addiction therapeutic pipelines from concept through toxicology and Phase I design. A PhD-trained biochemist with extensive postdoc experience, he combines deep mechanistic expertise in tumor and vascular biology with practical skills in ADME, safety pharmacology and formulation optimization. Eugene is also experienced in IP analysis, licensing diligence and outsourcing—routinely identifying and managing academic and CRO partnerships to accelerate programs. Notably, he has a track record of turning complex academic ideas into regulator-ready dossiers while coaching and building cross-disciplinary teams.
15 years of coding experience
6 years of employment as a software developer
MSc, Biochemistry, MSc, Biochemistry at Dnipropetrovs'kij Nacional'nij Universitet
PhD, Biochemistry, PhD, Biochemistry at USSR Academy of Science, Moscow